Berberine ameliorates diabetic cardiomyopathy in mice by decreasing cardiomyocyte apoptosis, oxidative stress: Study

by

Diabetic cardiomyopathy is a multifaceted complication of diabetes that lacks effective treatments. Berberine (BBR), a bioactive compound from Rhizoma coptidis, has potential therapeutic implications, but its precise role in diabetic cardiomyopathy has yet to be defined.

Leave A Comment

Your email address will not be published. Required fields are marked *